The management of CKD: a look into the future

Area of Science:

• Nephrology
• Fibrosis Research
• Translational Medicine

Background:

• Chronic kidney disease (CKD) and end-stage renal disease (ESRD) present significant global public health and economic challenges.
• Progressive kidney fibrosis is a hallmark of CKD, driving disease progression.
• Current treatments primarily focus on blood pressure control, with limited options targeting the fibrotic process itself.

Purpose of the Study:

• To review experimental therapeutic strategies for slowing CKD progression.
• To explore novel approaches that prevent or reverse kidney fibrosis.
• To highlight potential treatments targeting the underlying mechanisms of kidney remodeling.

Main Methods:

• Literature review of experimental studies on kidney fibrosis.
• Analysis of pathophysiologic steps in kidney remodeling.
• Exploration of therapeutic targets for fibrotic processes.

Main Results:

• Limited current therapies exist for targeting kidney fibrosis directly.
• Experimental strategies show promise in preventing or reversing fibrosis.
• Understanding kidney remodeling pathways is key to developing new treatments.

Conclusions:

• Novel therapeutic strategies targeting kidney fibrosis are crucial for managing CKD.
• Experimental approaches offer potential for slowing CKD progression.
• Further research into fibrotic mechanisms may yield effective treatments.